Drug Shortage Report for APO-MOMETASONE

Last updated on 2022-09-15 History
Report ID 168418
Drug Identification Number 02403587
Brand name APO-MOMETASONE
Common or Proper name MOMETASONE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 50MCG
Dosage form(s) SPRAY, METERED DOSE
Route of administration NASAL NASAL
Packaging size 140 MS
ATC code R01AD
ATC description DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-29
Estimated end date 2022-09-16
Actual end date 2022-09-14
Shortage status Resolved
Updated date 2022-09-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-09-15 English Compare
v2 2022-09-01 French Compare
v1 2022-09-01 English Compare

Showing 1 to 3 of 3